Journal article
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study
- Abstract:
-
The application of radionuclide-labeled biomolecules such as monoclonal antibodies or antibody fragments for imaging purposes is called immunoscintigraphy. More specifically, when the nuclides used are positron emitters, such as zirconium-89, the technique is referred to as immuno-PET. Currently, there is an urgent need for radionuclides with a half-life which correlates well with the biological kinetics of the biomolecules under question and which can be attached to the proteins by robust la...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 668.3KB)
-
- Publisher copy:
- 10.1016/j.nucmedbio.2016.02.003
Authors
Funding
Program for the Promotion of the Exchange and Scientific Cooperation between Greece and Germany IKYDA
More from this funder
COST ActionTD1004
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Nuclear Medicine and Biology Journal website
- Volume:
- 43
- Issue:
- 5
- Pages:
- 280-287
- Publication date:
- 2016-02-14
- Acceptance date:
- 2016-02-04
- DOI:
- EISSN:
-
1872-9614
- ISSN:
-
0969-8051
- Source identifiers:
-
612938
Item Description
- Keywords:
- Pubs id:
-
pubs:612938
- UUID:
-
uuid:d1cb150e-d6ac-4793-a3d3-bd9814471b23
- Local pid:
- pubs:612938
- Deposit date:
- 2016-04-22
Terms of use
- Copyright holder:
- Society of Radiopharmaceutical Sciences
- Copyright date:
- 2016
- Notes:
- Published by Elsevier Inc. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: [10.1016/j.nucmedbio.2016.02.003]
If you are the owner of this record, you can report an update to it here: Report update to this record